|
|
40
|
|
|
A6931
|
|
|
TRILEPTAL 60MG/ML SUSP (NVS/COL) OXCARBAZEPIN
|
|
|
OXCARBAZEPINE
|
|
|
TRILEPTAL
|
|
|
100ML
|
|
|
A
|
|
|
27.35
|
|
|
0.27
|
|
|
60MG/ML
|
|
|
SUSPENSION
|
|
|
600
|
|
|
ML
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Epileptic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|